Supernus Pharmaceuticals, Inc. (SUPN)
USD 35.46
(-2.1%)
USD 35.46
(-2.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 607.52 Million | 667.23 Million | 579.77 Million | 520.39 Million | 392.75 Million | 408.89 Million |
| Cost of Revenue | 83.77 Million | 87.22 Million | 75.06 Million | 52.45 Million | 16.66 Million | 15.35 Million |
| Gross Profit | 523.74 Million | 580.01 Million | 504.71 Million | 467.93 Million | 376.09 Million | 393.54 Million |
| Operating Expenses | 529.01 Million | 534.4 Million | 425.21 Million | 292.34 Million | 227.52 Million | 249.09 Million |
| Selling, General and Administrative Expenses | 336.36 Million | 377.22 Million | 304.75 Million | 200.67 Million | 158.42 Million | 159.88 Million |
| Research and Development Expenses | 91.59 Million | 74.55 Million | 90.46 Million | 75.96 Million | 69.09 Million | 89.2 Million |
| Other Expenses | 101.05 Million | 82.63 Million | 29.98 Million | 15.7 Million | - | - |
| Cost and Expenses | 612.79 Million | 621.62 Million | 500.27 Million | 344.79 Million | 244.18 Million | 264.45 Million |
| Operating Income | -5.26 Million | 67.3 Million | 86.02 Million | 173.69 Million | 148.57 Million | 144.44 Million |
| Interest Expense | 2.41 Million | 7.07 Million | 23.42 Million | 23.75 Million | 22.7 Million | 18.11 Million |
| Income Tax Expense | 1.45 Million | 32 Thousand | 19.75 Million | 41.69 Million | 34.43 Million | 29.18 Million |
| Earnings before Tax | 2.76 Million | 60.74 Million | 73.17 Million | 168.64 Million | 147.48 Million | 140.17 Million |
| Net Income | 1.31 Million | 60.71 Million | 53.42 Million | 126.95 Million | 113.05 Million | 110.99 Million |
| Earnings Per Share Basic | 0.02 | 1.13 | 1.01 | 2.41 | 2.16 | 2.13 |
| Earnings Per Share Diluted | 0.02 | 1.04 | 0.98 | 2.36 | 2.10 | 2.05 |
| Weighted Average Shares Outstanding | 54.53 Million | 53.66 Million | 53.09 Million | 52.61 Million | 52.41 Million | 51.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.5 Million | 61.67 Million | 54.35 Million | 53.68 Million | 53.81 Million | 54.09 Million |
| Gross Margin | 0.86 | 0.87 | 0.87 | 0.90 | 0.96 | 0.96 |
| EBIT Margin | 0.16 | 0.22 | 0.21 | 0.40 | 0.43 | 0.39 |
| Profit Margin | 0.00 | 0.09 | 0.09 | 0.24 | 0.29 | 0.27 |
| EBITDA | 98.26 Million | 153.44 Million | 129.18 Million | 212.4 Million | 180.41 Million | 151.5 Million |
| Earnings Before Tax Margin | -0.01 | 0.10 | 0.15 | 0.33 | 0.38 | 0.35 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 175.68 Million | 168.32 Million | 143.64 Million | 164.31 Million | 607.52 Million | 153.88 Million |
| Cost of Revenue | 37.67 Million | 38.62 Million | 37.05 Million | 41.3 Million | 168.63 Million | 19.6 Million |
| Gross Profit | 138.01 Million | 129.7 Million | 106.58 Million | 123.01 Million | 438.88 Million | 134.27 Million |
| Operating Expenses | 98.78 Million | 111.48 Million | 110.83 Million | 104.02 Million | 425.48 Million | 126.59 Million |
| Selling, General and Administrative Expenses | 69.75 Million | 85.9 Million | 86.51 Million | 81.28 Million | - | 82.7 Million |
| Research and Development Expenses | 29.03 Million | 25.58 Million | 24.31 Million | 22.74 Million | - | 22.65 Million |
| Other Expenses | - | 15.75 Million | - | -19.96 Million | - | - |
| Cost and Expenses | 134.84 Million | 150.11 Million | 147.89 Million | 145.32 Million | 594.11 Million | 146.19 Million |
| Operating Income | 40.84 Million | 18.21 Million | -4.24 Million | 18.98 Million | 13.4 Million | 8.13 Million |
| Interest Expense | - | - | - | -4.83 Million | 2.41 Million | - |
| Income Tax Expense | 6.44 Million | 6.38 Million | 119 Thousand | -185 Thousand | 1.45 Million | 25.86 Million |
| Earnings before Tax | 44.94 Million | 26.3 Million | 243 Thousand | 990 Thousand | 2.76 Million | 9.88 Million |
| Net Income | 38.49 Million | 19.91 Million | 124 Thousand | 1.17 Million | 1.31 Million | -15.97 Million |
| Earnings Per Share Basic | 0.70 | 0.36 | 0.00 | 0.02 | - | -0.29 |
| Earnings Per Share Diluted | 0.69 | 0.36 | 0.00 | 0.02 | - | -0.29 |
| Weighted Average Shares Outstanding | 55.14 Million | 54.97 Million | 54.8 Million | 54.64 Million | 54.53 Million | 54.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 56.01 Million | 55.72 Million | 55.62 Million | 55.3 Million | 55.5 Million | 54.6 Million |
| Gross Margin | 0.79 | 0.77 | 0.74 | 0.75 | 0.72 | 0.87 |
| EBIT Margin | 0.23 | 0.23 | 0.11 | 0.25 | - | 0.20 |
| Profit Margin | 0.22 | 0.12 | 0.00 | 0.01 | 0.00 | -0.10 |
| EBITDA | 40.84 Million | 38.92 Million | 16.5 Million | 40.66 Million | - | 31.29 Million |
| Earnings Before Tax Margin | 0.23 | 0.11 | -0.03 | 0.12 | 0.02 | 0.05 |
GMEXICOB
3236
IVFH
KG
FORCEMOT
1929